Dietary supplement compositions
This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.
1. A composition comprising:
(a) between about 100 mg and about 3000 mg of acetyl-L-carnitine, wherein at least 40% said composition is said acetyl-L-carnitine,
(b) between about 25 mg to about 500 mg of Bacopa monnieri extract, wherein at least 20% of said composition is said Bacopa monnieri extract, and
(c) between about 10 mg and about 500 mg of curcumin,
wherein said composition is in the form of a tablet or is within a capsule.
2. The composition of claim 1 , wherein said composition further comprises between about 10 IU and about 800 IU of Vitamin E.
3. The composition of claim 1 , wherein said composition further comprises between about 0.14 mg and about 20 mg of folic acid.
4. The composition of claim 1 , wherein said composition further comprises between about 0.3 mg and 1.0 mg of folic acid.
5. The composition of claim 1 , wherein said composition is in the form of the tablet.
6. The composition of claim 1 , wherein said composition is in the form of multiple tablets or capsules.
7. A composition comprising:
(a) between about 200 mg and about 3000 mg of acetyl-L-carnitine, wherein at least 40% of said composition is said acetyl-L-carnitine,
(b) between about 50 mg to about 1000 mg of Bacopa monnieri extract, wherein at least 20% of said composition is said Bacopa monnieri extract,
(c) between about 25 mg and about 400 mg of curcumin,
(d) between about 100 IU and about 800 IU of Vitamin E, and
(e) between about 0.006 mg and about 2.5 mg of Vitamin B12;
wherein said composition is in the form of a tablet or is within a capsule.
8. A composition comprising:
(a) acetyl-L-carnitine, wherein at least 40% of said composition is said acetyl-L-carnitine,
(b) at least about 25 mg of Bacopa monnieri extract, wherein at least 20% of said composition is said Bacopa monnieri extract,
(c) at least about 10 mg of a curcuminoid,
(d) at least about 10 IU of Vitamin E, and
(e) at least about 0.006 mg of Vitamin B12,
wherein said composition is in the form of a tablet or is within a capsule.
9. The composition of claim 5 , wherein the tablet comprises a coating.
10. The composition of claim 9 , wherein the coating is a polysaccharide-based coating.
11. The composition of claim 9 , wherein the coating comprises a polymer.
12. The composition of claim 7 , wherein said composition is in the form of the tablet.
13. The composition of claim 12 , wherein the tablet comprises a coating.
14. The composition of claim 13 , wherein the coating is a polysaccharide-based coating.
15. The composition of claim 13 , wherein the coating comprises a polymer.
16. The composition of claim 7 , wherein said composition is in the form of multiple tablets or capsules.
17. The composition of claim 8 , wherein said composition is in the form of the tablet.
18. The composition of claim 17 , wherein the tablet comprises a coating.
19. The composition of claim 18 , wherein the coating is a polysaccharide-based coating.
20. The composition of claim 18 , wherein the coating comprises a polymer.
21. The composition of claim 8 , wherein said composition is in the form of multiple tablets or capsules.
22. The composition of claim 1 , further comprising between about 0.01 mg and about 8 mg of huperzine A.
23. The composition of claim 7 , further comprising between about 0.01 mg and about 0.40 mg of huperzine A.
24. The composition of claim 8 , further comprising at least about 0.01 mg of an acetylcholinesterase inhibitor.
25. The composition of claim 7 , further comprising between about 0.1 mg and about 10 mg of folic acid.
26. The composition of claim 8 , further comprising at least about 0.1 mg of folic acid.